Choice Rehab & Pain Clinic, Pc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1638 Schlosser St, D4 Ste 2, Fort Lee, NJ 07024 Phone: 201-403-7733 |
Ms. Ljiljana Dimitrijevic Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2340 Linwood Ave, 5a, Fort Lee, NJ 07024 Phone: 201-944-1562 |
Professional Occupational & Physical Therapy, Pllc Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2200 Fletcher Ave Ste 505, Fort Lee, NJ 07024 Phone: 201-849-5201 Fax: 201-849-5014 |
Alison Weiner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2185 Lemoine Ave, Apt 7m, Fort Lee, NJ 07024 Phone: 551-497-2100 |
Corrine Pineda, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1622 Parker Ave Ste 2b, Fort Lee, NJ 07024 Phone: 201-592-0800 |
Dr. Sharon A Gutman, PHD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6 Horizon Rd, Apt. 1007, Fort Lee, NJ 07024 Phone: 201-777-4411 |
Pan He Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2320 Linwood Ave Apt 2a, Fort Lee, NJ 07024 Phone: 917-887-7002 |
Mrs. Sara M. Rabinovich, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1604 Gerome Ave, Fort Lee, NJ 07024 Phone: 646-299-2194 |
News Archive
ValGenesis, Inc., a world-leading provider of Validation Lifecycle Management (VLM) software solutions, today announced that Bayer HealthCare AG has implemented ValGenesis software as their platform for validation process management at their Berkeley and Emeryville sites.
Will all Americans get health coverage as good as lawmakers' insurance under the overhaul, as Democrats pledged? Apparently so. Even though most federal workers will maintain their federally employee's benefits, lawmakers will have to sign up for insurance plans through the new, state-run exchanges offered through the health legislation (Barry, 3/31).
In a randomized Phase III study of the drug inotuzumab ozogamicin, a statistically significant percentage of patients with acute lymphoblastic leukemia (ALL) whose disease had relapsed following standard therapies, qualified for stem cell transplants.
Fatal snakebites are a bigger-than-acknowledged global health problem that has been vastly under-reported, according to research presented today at the American Society of Tropical Medicine and Hygiene's (ASTMH) annual meeting.
Mild cognitive impairment (MCI) is under the pharma' spotlight as the number of clinical trials currently underway has increased significantly during the past 12 months and the search for treatments that will prevent the progression of MCI to dementia continues. Synexus has teamed up with dementia expert, Dr Roger Bullock, to develop more effective clinical trials for this field.
› Verified 4 days ago